Cornerstone Robotics Secures $70 Million to Accelerate Global Expansion of Surgical Robotics

Cornerstone Robotics, a global startup in surgical robotics, has successfully secured over $70 million in Series C funding. The investment round was led by EQT and included investors such as Qiming Venture Partners, Alpha JWC Ventures, eGarden Ventures, and others.

This financial boost will help Cornerstone Robotics accelerate the commercialization of its advanced surgical systems, support clinical trials, obtain regulatory approvals, and drive global adoption of its robotic solutions in the healthcare sector.

Cornerstone Robotics, founded in September 2019 and headquartered in Hong Kong and the Greater Bay Area, has rapidly established itself as a key player in the surgical robotics sector. Through a combination of in-house research and development and a vertically integrated supply chain, Cornerstone Robotics has been able to offer high-performance systems at competitive prices, with partnerships with leading medical institutions in mainland China, Hong Kong, and Europe.

The company has partnered with prestigious institutions such as the Faculty of Medicine at the Chinese University of Hong Kong and the Chinese University of Hong Kong-Shenzhen Medicine. Its successful clinical trials in general surgery, urology, gynecology, and thoracic surgeries have paved the way for its global expansion. These achievements were further solidified when Cornerstone Robotics received approval from China’s National Medical Products Administration (NMPA) for its innovative Endoscopic Surgical System, “Sentire.”

The company has shown global growth, with plans to expand into key markets, including Europe and Southeast Asia. With additional support from the Hong Kong government’s Innovation and Technology Venture Fund, Cornerstone Robotics is set to accelerate its commercialization process, conduct further clinical trials, and expand its product line. 

Professor Samuel Au, the founder and CEO of Cornerstone Robotics, expressed gratitude to shareholders for their trust and noted that the milestones achieved, including NMPA approval, are a testament to the company’s successful execution of its vision. Going forward, Cornerstone Robotics will continue to drive innovation, secure international certifications, and boost partnerships to revolutionize the surgical robotics industry and improve healthcare outcomes worldwide.

Clara Ho and Gordon Shaw, Partners at EQT Private Capital Asia, emphasized the growing global demand for accessible, high-quality robot-assisted surgical treatments. They pointed out that only a few companies possess the expertise required to meet the stringent standards of such critical procedures. They commended Cornerstone Robotics for its leadership in the industry, merging cutting-edge medical robotics with a strong commitment to broadening access to healthcare.

Cornerstone Robotics opened a new site in the United Kingdom in 2024 as part of its expansion strategy. The site is expected to support advanced research and enhance the company’s ability to serve patients across Europe and other global markets.